Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation. The methodologies for generating tolAPC vary greatly between different laboratories, making...

Descripción completa

Detalles Bibliográficos
Autores principales: Lord, Phillip, Spiering, Rachel, Aguillon, Juan C., Anderson, Amy E., Appel, Silke, Benitez-Ribas, Daniel, ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K., Giannoukakis, Nick, Gregori, Silvia, van Ham, S. Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A., Hutchinson, James A., Isaacs, John D., Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W., Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M., Hilkens, Catharien M.U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012269/
https://www.ncbi.nlm.nih.gov/pubmed/27635311
http://dx.doi.org/10.7717/peerj.2300

Ejemplares similares

Ejemplares similares